Skip to main content
Clinical Trials/NCT02727140
NCT02727140CompletedNot Applicable

Yoga as a Supportive Therapy for Patients With Hypertension: A Randomized Controlled Trial

Universität Duisburg-Essen1 site in 1 country75 target enrollmentStarted: May 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
75
Locations
1
Primary Endpoint
24 h mean value of systolic and diastolic blood pressure

Study Overview

Brief Summary

The proposed study aims to investigate the feasibility, effectiveness, and perceived benefit of a supportive hatha yoga intervention for patients with hypertension using antihypertensive drugs. Patients will be randomized into 3 groups comparing hatha yoga with yoga postures, breathing and relaxation techniques to a hatha yoga intervention without yoga postures (only breathing and relaxation techniques) as well as to a wait list control group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • essential Hypertension
  • stable antihypertensive medication during the next 6 months

Exclusion Criteria

  • pregnancy or breast feeding
  • simultaneous participation in further clinical intervention trials
  • regular yoga practice in the past 12 months
  • serious mental illness (severe depression, severe addiction, psychosis)
  • manifest coronary heart disease that has been treated in the past 3 months or myocardial infarction, embolism of pulmonary arteries or stroke in the past 3 months
  • heart failure ≥ state 1 New York Heart Association (NYHA)
  • peripheral arterial occlusive disease ≥ state 1
  • renal insufficiency > state 2, glomerular filtration rate < 60 ml/min/1,73m² according to he National Kidney Foundation (NKF)

Outcomes

Primary Outcomes

24 h mean value of systolic and diastolic blood pressure

Time Frame: 12 weeks

Secondary Outcomes

  • Health-related Quality of Life(28 weeks)
  • Subjective Stress(28 weeks)
  • Adverse Events(28 weeks)
  • 24 h mean value of systolic and diastolic blood pressure(28 weeks)
  • Emotional Distress(28 weeks)
  • Nutrition habits(28 weeks)
  • Physical activity(28 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Holger Cramer

Research director

Universität Duisburg-Essen

Study Sites (1)

Loading locations...

Similar Trials